Teva Pharmaceutical Industries Ltd.
said Tuesday its FDA-approved generic version of the EpiPen is available in the U.S. at most retail pharmacies at a wholesale cost of $300 for a 2-pack. The news comes after a period of shortages for the EpiPen, a life-saving allergy treatment that is made by Mylan N.V.
The Teva generic uses Antares Pharma
VIBEX(R) device. Antares and Teva have an exclusive license, development and supply Agreement for epinephrine auto injector products that Teva markets in the U.S. Teva shares rose 0.6% premarket, but have fallen 57% in 2019, while the S&P 500
has gained 17″%.
Go to Source